ArticleCancer biology & therapy2017

Chronic myelomonocytic leukemia with double-mutations in DNMT3A and FLT3-ITD treated with decitabine and sorafenib.

Jia Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.